The European medicines regulator has started a real-time review of Sinovac’s Covid-19 vaccine, with the drug becoming the first Chinese-developed jab to be evaluated by the bloc.
The launch of the so-called “rolling review” was announced by the European Medicines Agency (EMA) on Tuesday.
Continue reading https://on.rt.com/b7ff